Where Does Wall Street Think Twist Bioscience Corp (TWST) Stock Will Go?

Friday, March 08, 2024 11:53 AM | InvestorsObserver Analysts

Mentioned in this article

Wall Street is positive on Twist Bioscience Corp (TWST). On average, analysts give the stock a Strong Buy rating. The average price target is $37.625, which means analysts expect the stock to fall by -2.42% over the next twelve months. That average ranking earns the stock an Analyst Rating of 52, which is better than 52% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating TWST a Strong Buy today. Find out what this means to you and get the rest of the rankings on TWST!
See Full TWST Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Twist Bioscience Corp Stock Today?

Twist Bioscience Corp (TWST) stock is higher by 1.49% while the S&P 500 is lower by -0.04% as of 11:51 AM on Friday, Mar 8. TWST is up $0.57 from the previous closing price of $37.99 on volume of 270,849 shares. Over the past year the S&P 500 is higher by 31.57% while TWST is up 124.71%. TWST lost -$3.60 per share the over the last 12 months. Click Here to get the full Stock Report for Twist Bioscience Corp stock.

Share this article:

Related Articles